Physician profile
Timothy Lee
NPI 1790736650
$2,159.19
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,269 · 2020: $156 · 2021: $499 · 2022: $235.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $193.32 | 2021-2022 | |
| Amgen INC. | $190.24 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $178.17 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $165.94 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $163.55 | 2019-2020 | |
| Ucb, INC. | $124.78 | 2019 | |
| Supernus Pharmaceuticals, INC. | $114.96 | 2019 | |
| Genzyme Corporation | $103.74 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $77.99 | 2021 | |
| Biogen, INC. | $73.72 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $72.56 | 2019 | |
| Eisai INC. | $49.21 | 2019-2022 | |
| Theratechnologies INC. | $47.58 | 2021 | |
| Nestle Healthcare Nutrition INC. | $43.83 | 2021 | |
| Novo Nordisk INC | $37.97 | 2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $36.87 | 2021-2022 | |
| Emd Serono, INC. | $36.62 | 2019 | |
| Medtronic, INC. | $33.82 | 2022 | |
| Allergan, INC. | $33.30 | 2019-2020 | |
| Esperion Therapeutics, INC. | $26.91 | 2021 | |
| Assertio Therapeutics, INC. | $25.27 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $24.89 | 2019 | |
| Akcea Therapeutics, INC. | $22.96 | 2019 | |
| Glaxosmithkline, LLC. | $22.35 | 2022 | |
| Genentech USA, INC. | $22.29 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $22.09 | 2022 | |
| Neurocrine Biosciences, INC. | $21.38 | 2020 | |
| Insulet Corporation | $19.70 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.00 | 2019 | |
| Jazz Pharmaceuticals INC. | $17.67 | 2019 | |
| Csl Behring | $17.24 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $17.06 | 2022 | |
| Upsher-Smith Laboratories LLC | $16.20 | 2019 | |
| Xeris Pharmaceuticals, INC. | $16.17 | 2022 | |
| Vertical Pharmaceuticals, LLC | $15.80 | 2019 | |
| Bausch Health US, LLC | $14.60 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.49 | 2021 | |
| Lilly USA, LLC | $13.66 | 2022 | |
| Lundbeck LLC | $12.29 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.